NASDAQ: MRAIMarpai Inc Stock
$2.05-0.05 (-2.38%)
Updated Dec 8, 2023
MRAI Price
$2.05
Fair Value Price
$3.32
Market Cap
$16.01M
52 Week Low
$0.33
52 Week High
$13.60
P/E
-0.38x
P/B
-1.73x
P/S
0.14x
PEG
N/A
Dividend Yield
N/A
Revenue
$36.08M
Earnings
-$32.26M
Gross Margin
35.3%
Operating Margin
-87.09%
Profit Margin
-89.4%
Debt to Equity
-4.85
Operating Cash Flow
-$35M
Beta
1.09
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MRAI Overview
Marpai Incorporated acts as a third-party-administrator for employers who self-insure healthcare benefits using AI technology branded as FutureSight Advantage. It services 40,000 members in 44 states. Marpai was incorporated in 2021 and is headquartered in New York, NY.
Zen Score
–
Industry Average (39)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MRAI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MRAI ($2.05) is undervalued by 38.34% relative to our estimate of its Fair Value price of $3.32 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MRAI ($2.05) is significantly undervalued by 38.34% relative to our estimate of its Fair Value price of $3.32 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MRAI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MRAI due diligence checks available for Premium users.
Be the first to know about important MRAI news, forecast changes, insider trades & much more!
MRAI News
Valuation
MRAI fair value
Fair Value of MRAI stock based on Discounted Cash Flow (DCF)
Price
$2.05
Fair Value
$3.32
Undervalued by
38.34%
MRAI ($2.05) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MRAI ($2.05) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MRAI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MRAI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.38x
Industry
20.23x
Market
31.32x
MRAI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-1.73x
Industry
3.17x
MRAI's financial health
Profit margin
Revenue
$8.7M
Net Income
-$7.3M
Profit Margin
-83.6%
MRAI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MRAI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$35.6M
Liabilities
$44.9M
Debt to equity
-4.85
MRAI's short-term liabilities ($20.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MRAI's long-term liabilities ($24.41M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MRAI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MRAI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$6.6M
Investing
$9.0k
Financing
$146.0
MRAI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MRAI vs Healthcare Plan Stocks
Marpai Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.